Caution: work in progress: While the methodological “revolution” deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised

European Journal of Epidemiology

Volumn 31, Issue 6, 2016, Pages 535-539

  Porta, Miquel ^a,b,c   Bolúmar, Francisco ^c,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b IL   (United States)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Clinical research; Directed acyclic graphs (DAGs); Methods; Paradox

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASTHMA; BIOINFORMATICS; BIOMEDICINE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; HUMAN; MATERNAL SMOKING; PREECLAMPSIA; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STUDY DESIGN; SYSTEMS BIOLOGY; EPIDEMIOLOGIST; EPIDEMIOLOGY; PERSONNEL; STATISTICAL BIAS; STATISTICAL MODEL;

BIAS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGISTS; EPIDEMIOLOGY; HUMANS; MODELS, STATISTICAL; RESEARCH PERSONNEL;

EID: 84978916742     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-016-0181-3     Document Type: Article

References (79)

1. Sudan M, Arah OA, Olsen J, Kheifets L. Reported associations between asthma and acute lymphoblastic leukemia: insights from a hybrid simulation study. Eur J Epidemiol. 2016. doi:10.1007/s10654-016-0126-x.
2. Dhana K, van Rosmalen J, Vistisen D, Ikram MA, Hofman A, Franco OH, Kavousi M. Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis. Eur J Epidemiol. 2016. doi: 10.1007/s10654-016-0131-0.
3. Luque-Fernandez MA, Zoega H, Valdimarsdottir U, Williams MA. Deconstructing the smoking-preeclampsia paradox through a counterfactual framework. Eur J Epidemiol. 2016. doi:10.1007/s10654-016-0139-5.
4. Li R, Daniel R, Rachet B. How much do tumor stage and treatment explain socioeconomic inequalities in breast cancer survival? Applying causal mediation analysis to population-based data. Eur J Epidemiol. 2016. doi:10.1007/s10654-016-0155-5.
5. Porta M, Vineis P, Bolúmar F. The current deconstruction of paradoxes: one sign of the ongoing methodological “revolution”. Eur J Epidemiol. 2015;30:1079–87.
6. Hernán MA, Sauer BC, Hernández-Díaz S, Platt R, Shrier I. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J Clin Epidemiol. 2016. doi:10.1016/j.jclinepi.2016.04.014.
7. Greenland S, Mansournia MA, Altman DG. Sparse data bias: a problem hiding in plain sight. BMJ. 2016;27(352):i1981.
8. Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183:758–64.
9. Pearce N. Analysis of matched case–control studies. BMJ. 2016;352:i969.
10. Greenland S. Concepts and pitfalls in measuring and interpreting attributable fractions, prevented fractions, and causation probabilities. Ann Epidemiol. 2015;25:155–61.
11. Goodman SN, Fanelli D, Ioannidis JP. What does research reproducibility mean? Sci Transl Med. 2016;8:341ps12.
12. Ioannidis JP, Fanelli D, Dunne DD, Goodman SN. Meta-research: evaluation and improvement of research methods and practices. PLoS Biol. 2015;13:e1002264.
13. Greenland S, Pearce N. Statistical foundations for model-based adjustments. Annu Rev Public Health. 2015;36:89–108.
14. Soonawala D, Dekkers OM, Vandenbroucke JP, Egger M. Noninferiority is (too) common in noninferiority trials. J Clin Epidemiol. 2016;71:118–20.
15. Greenland S, Mansournia MA. Penalization, bias reduction, and default priors in logistic and related categorical and survival regressions. Stat Med. 2015;34:3133–43.
16. Vandenbroucke JP, Broadbent A, Pearce N. Causality and causal inference in epidemiology: the need for a pluralistic approach. Int J Epidemiol. 2016. doi:10.1093/ije/dyv341.
17. Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC, Greenland S. Good practices for quantitative bias analysis. Int J Epidemiol. 2014;43:1969–85.
18. Greenland S, Daniel R, Pearce N. Outcome modelling strategies in epidemiology: traditional methods and basic alternatives. Int J Epidemiol. 2016;45:565–75.
19. Pizzi C, Pearce N, Richiardi L. Noncollapsibility in studies based on nonrepresentative samples. Ann Epidemiol. 2015;25:955–8.
20. Bolúmar F, Porta M. Epidemiologic methods: beyond clinical medicine, beyond epidemiology. Eur J Epidemiol. 2004;19:733–5.
21. Pearl J. Causality: models, reasoning and inference. 2nd ed. Cambridge: Cambridge University Press; 2009.
22. Hernán MA, Robins JM. Causal inference. New York: Chapman & Hall/CRC; 2017. http://www.hsph.harvard.edu/miguel-hernan/causal-inference-book.
23. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48.
24. Robins JM. Data, design, and background knowledge in etiologic inference. Epidemiology. 2001;12:313–20.
25. Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155:176–84.
26. Hernández-Díaz S, Schisterman EF, Hernán MA. The birth weight “paradox” uncovered? Am J Epidemiol. 2006;164:1115–20.
27. Hernández-Díaz S, Wilcox AJ, Schisterman EF, Hernán MA. From causal diagrams to birth weight-specific curves of infant mortality. Eur J Epidemiol. 2008;23:163–6.
28. Snoep JD, Morabia A, Hernández-Díaz S, Hernán MA, Vandenbroucke JP. A structural approach to Berkson’s fallacy. And a guide to a history of opinions about it. Int J Epidemiol. 2014;43:515–21.
29. Greenland S. Quantifying biases in causal models: classical confounding vs. collider-stratification bias. Epidemiology. 2003;14:300–6.
30. Richiardi L, Barone-Adesi F, Merletti F, Pearce N. Using directed acyclic graphs to consider adjustment for socioeconomic status in occupational cancer studies. J Epidemiol Community Health. 2008;62:e14.
31. Pearce N, Richiardi L. Three worlds collide: Berkson’s bias, selection bias and collider bias. Int J Epidemiol. 2014;43:521–4.
32. Aalen O, Røysland K, Gran J, Kouyos R, Lange T. Can we believe the DAGs? A comment on the relationship between causal DAGs and mechanisms. Stat Methods Med Res. 2014;1:1-21. http://smm.sagepub.com/content/early/2014/03/27/0962280213520436.full.pdf+html. Accessed 7 July 2016.
33. Geneletti SG, Gallo V, Porta M, Khoury MJ, Vineis P. Assessing causal relationships in genomics: from Bradford–Hill criteria to complex gene–environment interactions and directed acyclic graphs. Emerg Themes Epidemiol. 2011;8:5. http://www.ete-online.com/content/8/1/5.
34. Pearl J. Are economists smarter than epidemiologists? Comments on Imbens’s recent paper. Causal analysis in theory and practice [Blog]. October 27, 2014. http://www.mii.ucla.edu/causality/?p=1241. Accessed 7 July 2016.
35. Greenland S, Mansournia MA. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness. Eur J Epidemiol. 2015. doi:10.1007/s10654-015-9995-7.
36. Glass TA, Goodman SN, Hernán MA, Samet JM. Causal inference in public health. Annu Rev Public Health. 2013;34:61–75.
37. VanderWeele TJ, Vansteelandt S, Robins JM. Marginal structural models for sufficient cause interactions. Am J Epidemiol. 2010;1717:506–14.
38. Robins JM, Hernán MA, Brumbach B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550–60.
39. Van der Weele TJ, Hernán MA. From counterfactuals to sufficient component causes and vice versa. Eur J Epidemiol. 2006;21:855–8.
40. Hernán MA, Robins JM. Instruments for causal inference:an epidemiologist’s dream? Epidemiology. 2006;17:360–72.
41. Tong S, Neale RE, Shen X, Olsen J. Challenges for epidemiologic research on the verge of a new era. Eur J Epidemiol. 2011;26:689–94.
42. Pearce N. Epidemiology in a changing world: variation, causation and ubiquitous risk factors. Int J Epidemiol. 2011;40:503–12.
43. Porta M, Álvarez-Dardet C. Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health. 1998;52:605.
44. Hernán MA, Clayton D, Keiding N. The Simpson’s paradox unraveled. Int J Epidemiol. 2011;40:780–5.
45. Hernán MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19:766–79.
46. Dal Maso L, Torelli N, Biancotto E, Di Maso M, Gini A, Franchin G, Levi F, La Vecchia C, Serraino D, Polesel J. Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case–control studies using bi-dimensional spline models. Eur J Epidemiol. 2016;31:385–93.
47. Teljeur C, Kelly A, Loane M, Densem J, Dolk H. Using scan statistics for congenital anomalies surveillance: the EUROCAT methodology. Eur J Epidemiol. 2015;30:1165–73.
48. Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337–50.
49. Wang A, Arah OA. G-computation demonstration in causal mediation analysis. Eur J Epidemiol. 2015;30:1119–27.
50. Rydell M, Granath F, Cnattingius S, Magnusson C, Galanti MR. In-utero exposure to maternal smoking is not linked to tobacco use in adulthood after controlling for genetic and family influences: a Swedish sibling study. Eur J Epidemiol. 2014;29:499–506.
51. Sjölander A, Lee W, Källberg H, Pawitan Y. Bounds on sufficient-cause interaction. Eur J Epidemiol. 2014;29:813–20.
52. Niedziela J, Hudzik B, Niedziela N, Gąsior M, Gierlotka M, Wasilewski J, Myrda K, Lekston A, Poloński L, Rozentryt P. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29:801–12.
53. Stenzel SL, Ahn J, Boonstra PS, Gruber SB, Mukherjee B. The impact of exposure-biased sampling designs on detection of gene–environment interactions in case–control studies with potential exposure misclassification. Eur J Epidemiol. 2015;30:413–23.
54. Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH, Tiemeier HW, Uitterlinden AG, Vernooij MW. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30:661–708.
55. de Groot MC, Klungel OH, Leufkens HG, van Dijk L, Grobbee DE, van de Garde EM. Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia. Eur J Epidemiol. 2014;29:767–75.
56. Bamia C, Trichopoulos D. An anatomy of the way composite scores work. Eur J Epidemiol. 2015;30:473–83.
57. Thygesen LC, Ersbøll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29:551–8.
58. Waldram A, McKerr C, Gobin M, Adak G, Stuart JM, Cleary P. Control selection methods in recent case–control studies conducted as part of infectious disease outbreaks. Eur J Epidemiol. 2015;30:465–71.
59. O’Doherty MG, Jørgensen T, Borglykke A, Brenner H, Schöttker B, Wilsgaard T, et al. Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES). Eur J Epidemiol. 2014;29:887–97.
60. Kim RS. A new comparison of nested case–control and case–cohort designs and methods. Eur J Epidemiol. 2015;30:197–207.
61. de Keyser CE, Leening MJ, Romio SA, Jukema JW, Hofman A, Ikram MA, Franco OH, Stijnen T, Stricker BH. Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study. Eur J Epidemiol. 2014;29:841–50.
62. Korevaar TI, Steegers EA, de Rijke YB, Schalekamp-Timmermans S, Visser WE, Hofman A, Jaddoe VW, Tiemeier H, Visser TJ, Medici M, Peeters RP. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30:1057–66.
63. Medina-Gomez C, Felix JF, Estrada K, Peters MJ, Herrera L, Kruithof CJ, Duijts L, Hofman A, van Duijn CM, Uitterlinden AG, Jaddoe VW, Rivadeneira F. Challenges in conducting genome-wide association studies in highly admixed multi-ethnic populations: the Generation R Study. Eur J Epidemiol. 2015;30:317–30.
64. Keita AK, Fenollar F, Socolovschi C, Ratmanov P, Bassene H, Sokhna C, Tall A, Mediannikov O, Raoult D. The detection of vector-borne-disease-related DNA in human stool paves the way to large epidemiological studies. Eur J Epidemiol. 2015;30:1021–6.
65. Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543–52.
66. Ioannidis JP. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol. 2016;73:82–6.
67. Ioannidis JP. Why most clinical research is not useful. PLoS Med. 2016;13:e1002049.
68. Erren TC, Shaw DM, Groß JV. How to avoid haste and waste in occupational, environmental and public health research. J Epidemiol Community Health. 2015;69:823–5.
69. Morabia A. Has epidemiology become infatuated with methods? A historical perspective on the place of methods during the classical (1945–1965) phase of epidemiology. Annu Rev Public Health. 2015;36:69–88.
70. Porta M, Fernandez E, Belloc J, Malats N, Gallén M, Alonso J. Emergency admission for cancer: a matter of survival? Br J Cancer. 1998;77:477–84.
71. Fernandez E, Porta M, Malats N, Belloc J, Gallén M. Symptom to diagnosis interval and survival in cancers of the digestive tract. Dig Dis Sci. 2002;47:2434–40.
72. Macià F, Pumarega J, Gallén M, Porta M. Time from (clinical or certainty) diagnosis to treatment onset in cancer patients: the choice of diagnostic date strongly influences differences in therapeutic delay by tumor site and stage. J Clin Epidemiol. 2013;66:928–39.
73. Porta M, Malats N, Corominas JM, Rifà J, Piñol JL, Real FX. Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings. Ann Epidemiol. 2002;12:7–14.
74. Porta M, Malats N, Vioque J, Carrato C, Soler M, Ruiz L, Barberà V, Ayude D, Real FX. Incomplete overlapping of biological, clinical and environmental information in molecular epidemiologic studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health. 2002;56:734–8.
75. Porta M, Pumarega J, Ferrer-Armengou O, López T, Alguacil J, Malats N, Fernàndez E. Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study. Eur J Epidemiol. 2007;22:577–88.
76. Greaves MF. Aetiology of acute leukaemia. Lancet. 1997;349:344–9.
77. Schüz J, Ahlbom A. Exposure to electromagnetic fields and the risk of childhood leukaemia: a review. Radiat Prot Dosimetry. 2008;132:202–11.
78. Porta M, Greenland S, Hernán M, dos Santos Silva I, Last M, editors. A dictionary of epidemiology. 6th ed. New York: Oxford University Press; 2014.
79. VanderWeele TJ. Explanation in causal inference: methods for mediation and interaction. New York: Oxford University Press; 2015.